Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Godoy, W.
Right arrow Articles by Pinto, L. F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Godoy, W.
Right arrow Articles by Pinto, L. F. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 4, 611-616, April 2002
© 2002 Oxford University Press


CARCINOGENESIS

CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism

Wagner Godoy1, Rodolpho M. Albano1, Emanuela G. Moraes1, Paulo R. Alves Pinho2, Rodolfo A. Nunes3, Eduardo H. Saito3, Cláudio Higa3, Ivan M. Filho3, Cleber D. Pinto Kruel4, Carlos C. Schirmer4, Richard Gurski4, Matti A. Lang5 and Luis F. Ribeiro Pinto1,6

1 Departamento de Bioquímica, IBRAG, Universidade do Estado do Rio de Janeiro, RJ,
2 Disciplina de Gastroenterologia, Departamento de Medicina Interna, FCM–HUPE, Universidade do Estado do Rio de Janeiro, RJ,
3 Disciplina de Cirurgia Torácica, Departamento de Cirurgia Geral, FCM–HUPE, Universidade do Estado do Rio de Janeiro, RJ,
4 Departamento de Cirurgia Gástrica, FCM–HC, Universidade Federal do Rio Grande do Sul, RS, Brazil and
5 Department of Pharmaceutical Biosciences, Division of Biochemistry, Uppsala University, Uppsala, Sweden

Oesophageal cancer is one of the most common and lethal malignancies in the world. Despite many efforts, treatment is still ineffective for most cases; thus, the development of preventive strategies is crucial for decreasing the burden presented by this disease. Environmental factors, particularly nitrosamines, are thought to be involved in the genesis of oesophageal tumours, and knowledge about the expression of enzymes capable of activating pre-carcinogens in human oesophagus is very important for the development of preventive measures. We analysed the expression of CYP1A1, CYP1A2, CYP2A6/2A7, CYP2E1 and CYP3A4 mRNA in oesophageal mucosa of 50 patients by semi-quantitative RT-PCR. In five patients, who suffered from squamous cell carcinoma, we measured Nnitrosodimethylamine and N-nitrosodiethylamine metabolism in normal and tumorous tissue. CYP2A6/2A7 mRNA was expressed in 61% and CYP2E1 mRNA in 96% of the patients, but in the latter a lower degree of inter-individual variation was observed. These enzymes were expressed either in the distal or middle portions of the oesophagus of 90% of the patients. CYP1A1, CYP1A2 and CYP3A4 mRNA expression was not detected in any portion of the oesophagus. Oesophageal microsomes activated N-nitrosodimethylamine with a low degree of inter-individual variation and microsomes prepared from the tumour of a patient who strongly expressed CYP2A6/2A7 mRNA activated N-nitrosodiethylamine. We conclude that the human oesophagus expresses CYP2A6/2A7 and CYP2E1 and can activate nitrosamines. Notably, the expression of these enzymes is preferentially localized to the most common sites where tumours arise.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. Rossini, D.C.M. Rapozo, S.C. Soares Lima, D.P. Guimaraes, M.A. Ferreira, R. Teixeira, C.D.P. Kruel, S.G.S. Barros, N.A. Andreollo, R. Acatauassu, et al.
Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population
Carcinogenesis, December 1, 2007; 28(12): 2537 - 2542.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. Hukkanen, P. Jacob III, and N. L. Benowitz
Metabolism and Disposition Kinetics of Nicotine
Pharmacol. Rev., March 1, 2005; 57(1): 79 - 115.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
W J Lee, W Lijinsky, E F Heineman, R S Markin, D D Weisenburger, and M H Ward
Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus
Occup. Environ. Med., September 1, 2004; 61(9): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. C. E. McFadyen, W. T. Melvin, and G. I. Murray
Cytochrome P450 enzymes: Novel options for cancer therapeutics
Mol. Cancer Ther., March 1, 2004; 3(3): 363 - 371.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
E. Piras, A. Franzen, E. L. Fernandez, U. Bergstrom, F. Raffalli-Mathieu, M. Lang, and E. B. Brittebo
Cell-specific Expression of CYP2A5 in the Mouse Respiratory Tract: Effects of Olfactory Toxicants
J. Histochem. Cytochem., November 1, 2003; 51(11): 1545 - 1555.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.